Development of Novel pH-Sensitive Eudragit Coated Beads Containing Curcumin-Mesalamine Combination for Colon-Specific Drug Delivery
Gels · 23.03.2023 · 9 (4) · 264
DOI: 10.3390/gels9040264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gels, online erschienen am 23.03.2023. Verfasst von Eman J Heikal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This research aims to develop a drug delivery system that effectively treats colitis while administering curcumin/mesalamine by coating alginate/chitosan beads with Eudragit® S-100 to target the colon. Beads were tested to determine their physicochemical characteristics. Coating with Eudragit® S-100 prevents drug release at a pH of less than 7; this was demonstrated by in-vitro release conducted in a medium with gradually varying pH to mimic circumstances in various regions of the gastrointestinal tract. This study examined the efficacy of the coated beads in treating acetic acid-induced colitis in rats. Results showed that spherical beads were formed with an average diameter of 1.6–2.8 mm, and the obtained swelling ranged from 409.80% to 890.19%. The calculated entrapment efficiency ranged from 87.49% to 97.89%. The optimized formula F13 (which was composed of mesalamine-curcumin active ingredients, Sodium alginate as a gelling agent, chitosan as a controlled release agent, CaCl2 as a crosslinking agent, and Eudragit S-100 as a pH-sensitive coating agent) demonstrated the best entrapment efficiency (97.89% ± 1.66), swelling (890.19% ± 60.1), and bead size (2.7 ± 0.62 mm). In formulation #13, which was coated with Eudragit S 100, curcumin (6.01 ± 0.04%) and mesalamine (8.64 ± 0.7%), were released after 2 h at pH 1.2; 6.36 ± 0.11% and 10.45 ± 1.52% of curcumin and mesalamine, respectively, were then released after 4 h and at pH 6.8. Meanwhile, at pH 7.4, after 24 h, approximately 85.34 ± 2.3% (curcumin) and 91.5 ± 1.2% (mesalamine) were released. Formula #13 significantly reduced the colitis, and this suggests that the developed hydrogel beads can be used for delivering curcumin-mesalamine combinations to treat ulcerative colitis after adequate research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.
- Faculty of Pharmacy, The University of Mashreq, Baghdad 11001, Iraq.
- Pharmacy Department, Ashur University College, Baghdad 10047, Iraq.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sinai University-Kantara Branch, Ismailia 41636, Egypt.
- Department of Pharmacology & Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.
ORCID-Profile: Shadeed Gad, Hatem I Mokhtar, Abdullah Alattar, Sawsan A Zaitone
Zitieren
APA
Heikal, E. J., Kaoud, R. M., Gad, S., Mokhtar, H. I., Alattar, A., Alshaman, R., Zaitone, S. A., Moustafa, Y. M., & Hammady, T. M. (2023). Development of Novel pH-Sensitive Eudragit Coated Beads Containing Curcumin-Mesalamine Combination for Colon-Specific Drug Delivery. Gels, 9(4), 264. https://doi.org/10.3390/gels9040264
Vancouver
Heikal EJ, Kaoud RM, Gad S, Mokhtar HI, Alattar A, Alshaman R, et al. Development of Novel pH-Sensitive Eudragit Coated Beads Containing Curcumin-Mesalamine Combination for Colon-Specific Drug Delivery. Gels. 2023;9(4):264. doi:10.3390/gels9040264
BibTeX
@article{Heikal2023,
author = {Heikal, Eman J and Kaoud, Rashad M and Gad, Shadeed and Mokhtar, Hatem I and Alattar, Abdullah and Alshaman, Reem and Zaitone, Sawsan A and Moustafa, Yasser M and Hammady, Taha M},
title = {Development of Novel pH-Sensitive Eudragit Coated Beads Containing Curcumin-Mesalamine Combination for Colon-Specific Drug Delivery},
journal = {Gels},
year = {2023},
volume = {9},
number = {4},
pages = {264},
doi = {10.3390/gels9040264}
}
EUVIMED